Necrotic, rather than apoptotic, cell death caused by cytochrome P450–activated ifosfamide

被引:0
|
作者
Peter Karle
Matthias Renner
Brian Salmons
Walter H Günzburg
机构
[1] Institute of Virology,
[2] University of Veterinary Sciences,undefined
[3] Vienna,undefined
[4] Bavarian Nordic GmbH,undefined
[5] Austrian Nordic AG,undefined
来源
Cancer Gene Therapy | 2001年 / 8卷
关键词
Cytochrome P450 2B1; ifosfamide; necrosis; apoptosis; bystander effect; suicide gene;
D O I
暂无
中图分类号
学科分类号
摘要
Feline kidney cells were transfected with a vector overexpressing cytochrome P450 2B1 (CYP2B1). Transfected cells acquired a new specific biochemical activity, which could be demonstrated by a rapid CYP2B1 detection assay and showed selective sensitivity to the antitumorigenic prodrug ifosfamide (IFO). Further, the cell-killing effect was also mediated on nonmodified cells like feline kidney cells, mouse lymphoma, and human pancreatic cells in the vicinity of the CYP2B1-expressing cells due to the diffusible nature of the activated IFO metabolites. One of these, phosphoramide mustard, causes interstrand DNA cross-linking and it has been thought that the inability to repair this damage results in apoptosis. Surprisingly, our results clearly demonstrate a necrotic mechanism of IFO-induced cell death. This may have important implications for the activation of the immune system during CYP2B1/IFO suicide gene therapy of cancer. Cancer Gene Therapy (2001) 8, 220–230
引用
收藏
页码:220 / 230
页数:10
相关论文
共 50 条
  • [31] Co-expression of active human cytochrome P450 1A2 and cytochrome P450 reductase on the cell surface of Escherichia coli
    Quehl, Paul
    Hollender, Joel
    Schueuermann, Jan
    Brossette, Tatjana
    Maas, Ruth
    Jose, Joachim
    MICROBIAL CELL FACTORIES, 2016, 15
  • [32] Co-expression of active human cytochrome P450 1A2 and cytochrome P450 reductase on the cell surface of Escherichia coli
    Paul Quehl
    Joel Hollender
    Jan Schüürmann
    Tatjana Brossette
    Ruth Maas
    Joachim Jose
    Microbial Cell Factories, 15
  • [33] Pulmonary cytochrome P450 monooxygenase and Clara cell differentiation in mice
    Fanucchi, MV
    Murphy, ME
    Buckpitt, AR
    Philpot, RM
    Plopper, CG
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1997, 17 (03) : 302 - 314
  • [34] Cytochrome P450 promotes breast cancer cell proliferation.
    Mitra, Ranjana
    Srirangam, Anjaiah
    Capdevila, Jorge
    Potter, David A.
    CANCER RESEARCH, 2006, 66 (08)
  • [35] Cytochrome P450 and glutathione transferase expression in squamous cell cancer
    Ali, S
    El-Rayes, BF
    Heilbrun, LK
    Sarkar, FH
    Ensley, JF
    Kucuk, O
    Philip, PA
    CLINICAL CANCER RESEARCH, 2004, 10 (13) : 4412 - 4416
  • [36] Effect of Oridonin on Cytochrome P450 Expression and Activities in HepaRG Cell
    Zhang, Yi-wen
    Zheng, Xiao-wei
    Liu, Yu-jia
    Fang, Luo
    Pan, Zong-fu
    Bao, Mei-hua
    Huang, Ping
    PHARMACOLOGY, 2018, 101 (5-6) : 246 - 254
  • [37] Expression of cytochrome P450 in head and neck cancer cell lines
    Presa, Daniela F.
    Morais, Goreti Ribeiro
    Sutherland, Mark
    McCaul, Jim
    Robert, Jacques
    Patterson, Laurence
    Pors, Klaus
    CANCER RESEARCH, 2017, 77
  • [38] Cytochrome P450 2C Inhibitors Protect Photoreceptors from Light Induced Cell Death
    Bogaard, Joseph
    Chang, Qing
    Berdyshev, Evgeny A.
    Chen, Siquan
    Karumudi, Bhargava
    Wang, Yueting
    Driver, Tom G.
    Bettis, Sam
    Thatcher, Gregory R. J.
    Grassi, Michael A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [39] Cytochromes P450 .7. Role of the peroxisome proliferator-activated receptor in cytochrome P450 4A gene regulation
    Johnson, EF
    Palmer, CNA
    Griffin, KJ
    Hsu, MH
    FASEB JOURNAL, 1996, 10 (11): : 1241 - 1248
  • [40] Shosaikoto (a Kampo medicine) modulates changes in cytochrome P450 caused by Mycobacteriumbutyricum injection
    Nobukazu Ryu
    Hiroki Tanabe
    Toshiaki Makino
    Hajime Mizukami
    Makoto Inoue
    Journal of Natural Medicines, 2007, 61